Stockscreener 앱 받기
26.21
3.89%
0.99
전일 마감가:
$25.22
열려 있는:
$24.88
하루 거래량:
432.64K
Relative Volume:
0.74
시가총액:
$1.02B
수익:
$128.29M
순이익/손실:
$-30.69M
주가수익비율:
-31.96
EPS:
-0.82
순현금흐름:
$-27.17M
1주 성능:
+7.51%
1개월 성능:
-7.62%
6개월 성능:
-44.91%
1년 성능:
-48.04%
1일 변동 폭
$24.81
$26.38
1주일 범위
$24.24
$27.13
52주 변동 폭
$24.09
$66.54
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
RXST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
26.29 | 1.02B | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
131.59 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.09 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.25 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.57 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.79 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-10-29 | 개시 | Jefferies | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-05-07 | 재확인 | BTIG Research | Buy |
| 2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 개시 | Morgan Stanley | Overweight |
| 2023-04-13 | 개시 | Oppenheimer | Outperform |
| 2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight, Inc. (NASDAQ:RXST) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
BofA sees Bausch + Lomb IOL recall news as positive for RxSight - MSN
Midday Stock Roundup: Boot Barn, Beta Bionics down - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Swiss National Bank - Defense World
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Jefferies starts coverage on Rxsight with 'buy' on growth potential - TradingView
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Bank of America Issues Pessimistic Forecast for RxSight (NASDAQ:RXST) Stock Price - Defense World
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
BofA cuts RxSight stock price target to $36, maintains Buy rating - Investing.com Canada
RxSight price target lowered to $36 from $60 at BofA - TipRanks
BofA cuts RxSight stock price target to $36, maintains Buy rating By Investing.com - Investing.com South Africa
RxSight Inc. (RXST) PT Lowered to $36 at BofA Securities - StreetInsider.com
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $28.00 - Defense World
RxSight (NASDAQ:RXST) Hits New 52-Week Low on Analyst Downgrade - Defense World
RxSight stock plunges to 52-week low at $24.48 amid market shifts - Investing.com Australia
RxSight stock plunges to 52-week low at $24.48 amid market shifts By Investing.com - Investing.com South Africa
Bank of New York Mellon Corp Increases Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel cuts RxSight stock price target to $28 from $33 By Investing.com - Investing.com Canada
Stifel cuts RxSight stock price target to $28 from $33 - Investing.com
The Analyst Verdict: RxSight In The Eyes Of 9 Experts - Benzinga
RxSight Inc. (RXST) PT Lowered to $28 at Stifel - StreetInsider.com
RxSight price target lowered to $28 from $33 at Stifel - TipRanks
RxSight director Tamara Fountain sells $180,001 in company stock - Investing.com India
Victory Capital Management Inc. Raises Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Investment Analysts’ Recent Ratings Updates for RxSight (RXST) - Defense World
RxSight director Tamara Fountain sells $180,001 in company stock By Investing.com - Investing.com Australia
RxSight, Inc. (NASDAQ:RXST) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Principal Financial Group Inc. Purchases 3,879 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Rhumbline Advisers Boosts Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight stock plunges to 52-week low at $26.29 amid market challenges - Investing.com Australia
Glaukos, Tarsus, RxSight: Q4 Earnings Snapshot - Orange County Business Journal
How To Trade (RXST) - news.stocktradersdaily.com
RxSight's (RXST) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Wells Fargo & Company Cuts RxSight (NASDAQ:RXST) Price Target to $35.00 - Defense World
Global Retirement Partners LLC Acquires Shares of 2,000 RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel Nicolaus Cuts RxSight (NASDAQ:RXST) Price Target to $33.00 - Defense World
JPMorgan Chase & Co. Cuts RxSight (NASDAQ:RXST) Price Target to $40.00 - Defense World
RxSight’s (RXST) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
RxSight (NASDAQ:RXST) Issues Quarterly Earnings Results - MarketBeat
RxSight (NASDAQ:RXST) Price Target Lowered to $35.00 at Wells Fargo & Company - MarketBeat
New York State Common Retirement Fund Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - MarketBeat
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target - Simply Wall St
RxSight (NASDAQ:RXST) Shares Gap Down on Disappointing Earnings - Defense World
RxSight, Inc. Reports Strong Revenue Growth Amid Challenges - TipRanks
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
0.15%
자본화:
|
볼륨(24시간):